30 related articles for article (PubMed ID: 31711890)
1. Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma.
Migkou M; Avivi I; Gavriatopoulou M; Cohen YC; Fotiou D; Kanellias N; Ziogas D; Eleutherakis-Papaiakovou E; Terpos E; Roussou M; Kastritis E; Dimopoulos MA
Ann Hematol; 2020 Jun; 99(6):1251-1255. PubMed ID: 32307566
[TBL] [Abstract][Full Text] [Related]
2. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma clonal evolution in homogeneously treated patients.
Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
[TBL] [Abstract][Full Text] [Related]
4. Co-evolution of tumor and immune cells during progression of multiple myeloma.
Liu R; Gao Q; Foltz SM; Fowles JS; Yao L; Wang JT; Cao S; Sun H; Wendl MC; Sethuraman S; Weerasinghe A; Rettig MP; Storrs EP; Yoon CJ; Wyczalkowski MA; McMichael JF; Kohnen DR; King J; Goldsmith SR; O'Neal J; Fulton RS; Fronick CC; Ley TJ; Jayasinghe RG; Fiala MA; Oh ST; DiPersio JF; Vij R; Ding L
Nat Commun; 2021 May; 12(1):2559. PubMed ID: 33963182
[TBL] [Abstract][Full Text] [Related]
5. Positive selection as the unifying force for clonal evolution in multiple myeloma.
Diamond B; Yellapantula V; Rustad EH; Maclachlan KH; Mayerhoefer M; Kaiser M; Morgan G; Landgren O; Maura F
Leukemia; 2021 May; 35(5):1511-1515. PubMed ID: 33483619
[No Abstract] [Full Text] [Related]
6. Use of B-Cell Gene Rearrangement Studies to Establish Clonality in Non-producer Non-secretory Multiple Myeloma.
Mendoza H; Tormey CA; Siddon AJ
Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):e18-e21. PubMed ID: 31711890
[No Abstract] [Full Text] [Related]
7. [Chromosomal abnormalities and clonal evolution in multiple myeloma].
Ishida T
Rinsho Ketsueki; 2014 Oct; 55(10):2036-45. PubMed ID: 25297769
[No Abstract] [Full Text] [Related]
8. Clonal Evolution in Multiple Myeloma.
Fakhri B; Vij R
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
[TBL] [Abstract][Full Text] [Related]
9. Impact of Clonal Heterogeneity in Multiple Myeloma.
Schinke C; Rasche L; Raab MS; Weinhold N
Hematol Oncol Clin North Am; 2024 Apr; 38(2):461-476. PubMed ID: 38195308
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of clonal evolution in multiple myeloma.
Furukawa Y; Kikuchi J
Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
[TBL] [Abstract][Full Text] [Related]
11. Utilization of Analytical Omics Tools in the Molecular Diagnostics of Multiple Myeloma.
Kovacs Z; Guttman A
Curr Mol Med; 2018; 18(4):260-272. PubMed ID: 30295190
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
